September 26, 2016 1:20 AM ET

Healthcare Equipment and Supplies

Company Overview of Angiotech Pharmaceuticals Inc.

Executive Profile

Omar Vaishnavi

Director, Member of Audit Committee and Member of Governance, Nominating & Compensation Committee, Angiotech Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 0 different industries.

See Board Relationships
33--

Background

Mr. Omar Vaishnavi serves as a Senior Investment Analyst of BlueMountain Capital Management (“Blue Mountain”). Mr. Vaishnavi principally focuses on investing in credit and equities in a variety of industries. Mr. Vaishnavi served at Silver Point Capital as an investment professional with a primary focus on health care and distressed investing. He served as an Investment Banking Analyst at UBS. Mr. Vaishnavi has been a Director of Angiotech Pharmaceuticals Inc. since ...

Corporate Headquarters

355 Burrard Street
Vancouver, British Columbia V6C 2G8

Canada

Phone: 604-221-7676
Fax: 604-221-2330

Board Members Memberships

2011-Present
Director, Member of Audit Committee and Member of Governance, Nominating & Compensation Committee

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Angiotech Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.